CytoAgents is focused on the development of innovative pharmaceutical products for the treatment of symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system, commonly known as cytokine storm.
https://cytoagents.com/
Investors 3
Mentions in press and media 6
| Date | Title | Description | Source |
| 14.06.2021 | Meet the 7 life science startups of AlphaLab Health’s inaugu... | Seven promising life science startups started off 2020 with a shot of support from two of the region... | technical.... |
| 05.04.2021 | Seven early-stage health companies selected for Pittsburgh's... | Dr. Jeffrey Cohen, Chief Physician Executive for Community Health and Innovation at Allegheny Health... | prweb.com/... |
| 11.07.2020 | Broad Street Angels Hears Pitches from 3 Female CEO Entrepre... | Philadelphia, PA – Open for business and selecting high growth companies to pitch its members for in... | broadstree... |
| 13.05.2020 | Pittsburgh has long been a life sciences engine. Now it’s at... | If Dr. Louis Falo and his team at the University of Pittsburgh are successful, the same medical scho... | technical.... |
| - | CytoAgents Receives Second Round of NIH Funding to Accelerat... | PITTSBURGH--(BUSINESS WIRE)--Mar 10, 2021-- CytoAgents, a clinical stage biotechnology company focu... | oaoa.com/n... |
| - | CytoAgents | - | fastfounde... |